PFM Health Sciences’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

PFM Health Sciences’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,062	Closed	-$115K	–	126
2017 Q1	$115K	Sell	2,062 -368,999	-99%	-$18.5M	﹤0.01%	97
2016 Q4	$16.1M	Sell	371,061 -84,525	-19%	-$3.41M	0.46%	64
2016 Q3	$17.9M	Sell	455,586 -148,756	-25%	-$5.31M	0.52%	60
2016 Q2	$16.5M	Sell	604,342 -293,787	-33%	-$8.26M	0.5%	58
2016 Q1	$24.4M	Buy	898,129 +384,245	+75%	+$9.06M	0.75%	44
2015 Q4	$14.7M	Buy	513,884 +68,198	+15%	+$2.15M	0.45%	50
2015 Q3	$14.3M	Buy	+445,686	New	+$14.8M	0.4%	51

Other funds holding ZLTQ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PFM Health Sciences's ZLTQ Position: Q2 2017 in Review

PFM Health Sciences sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 2,062 shares — an estimated $115K sold.

PFM Health Sciences first reported a position in ZLTQ in Q3 2015 and held it in 7 quarters. The position peaked at $24.4M in Q1 2016. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.

PFM Health Sciences reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
PFM Health Sciences sold 2,062 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $115K.
PFM Health Sciences first reported a position in ZELTIQ Aesthetics, Inc. in Q3 2015 and held it in 7 quarters.
PFM Health Sciences's ZELTIQ Aesthetics, Inc. position peaked at $24.4M in Q1 2016.
2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.